Australasian Journal of Dermatology · 2019 · 10 citations · 5 references
MedicinePharmacologyPharmacotherapyAutoimmunityImmunopathologyRheumatologyAutoimmune DiseasesDemyelinating DiseasesDemyelinating DisordersImmunoglobulin DisordersImmunomodulatory Drug TherapyImmunomodulatory DrugsAutoimmune DemyelinationCase Series ReviewChronic Inflammatory Demyelinating PolyradiculoneuropathyDrug-induced DemyelinationInflammatory Demyelination
Drug-induced chronic cutaneous lupus erythematosus, or drug-induced discoid lupus erythematosus, is a rare cutaneous phenomenon. Various medications have been associated with drug-induced discoid lupus erythematosus including fluorouracile agents, especially tegafur and uraciltegafur, and TNF-α antagonists such as infliximab or etanercept. Recent literature has described a case series of six patients receiving IgG immunoglobulin for chronic inflammatory demyelinating polyneuropathy with subsequent presentations of discoid lupus erythematosus. We present a patient with chronic inflammatory demyelinating polyneuropathy who developed discoid lupus erythematosus secondary to IgG immunoglobulin.
5
Anti‐<scp>SSA</scp> antibodies are present in immunoglobulin preparations
Renate G. van der Molen, Dörte Hamann, Joannes F.M. Jacobs et al. · Transfusion · 2014 · 20 citations
Life Sciences, Immunology, Pathology +17
Max E. Adrichem, Markus V. Starink, Ester M. M. van Leeuwen et al. · Journal of the Peripheral Nervous System · 2017 · 20 citations · Full text
Medicine, Dermatology, Immunology +15